• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq – CNSL), Mirati Therapeutics, Inc.® (Nasdaq - MRTX), Pioneer Natural Resources (NYSE - PXD), Summit Materials (NYSE

By: Brodsky & Smith LLC via GlobeNewswire
October 16, 2023 at 14:59 PM EDT

BALA CYNWYD, Pa., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Mirati Therapeutics, Inc.® (Nasdaq - MRTX)

Under the terms of the Merger Agreement, Mirata will be acquired by Bristol Myers Squibb (NYSE - BMY) for $58.00 per share in cash for each share of Mirati held. The deal has a total equity value of $4.8 billion corresponding to an enterprise value of approximately $3.7 billion, which accounts for approximately $1.1 billion of Mirati cash. Each Mirati stockholder will also receive one non-tradeable CVR per Mirati share, which will entitle its holder to receive a one-time potential payment of $12.00 in cash, for a total value of approximately $1.0 billion. The investigation concerns whether the Mirati Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Bristol Myers Squibb is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/mirati-therapeutics-inc-nasdaq-mrtx/.

Pioneer Natural Resources (NYSE - PXD)

Under the terms of the agreement, Pioneer will be acquired by Exxon Mobil (NYSE – XOM). Holders of the Company’s shares will receive $253.00 in cash per share held. The deal has a market value of approximately $55.4 billion. The investigation concerns whether the Pioneer Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Exxon Mobil is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/pioneer-natural-resources-nyse-pxd/.

Consolidated Communications Holdings, Inc. (Nasdaq – CNSL)

Under the terms of the Merger Agreement, Consolidated Communications will be acquired by affiliates of Searchlight Capital Partners, L.P. (“Searchlight”) and British Columbia Investment Management Corporation (“BCI,” and together with Searchlight, the “Buyers”) in an all-cash transaction with an enterprise value of approximately $3.1 billion, including the assumption of debt. Buyers will acquire all of the Consolidated common stock not already owned by Searchlight for $4.70 per share in cash. The investigation concerns whether the Consolidated Communications Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Buyers are paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/consolidated-communications-holdings-inc-nasdaq-cnsl/ .

Summit Materials (NYSE - SUM)

Under the terms of the agreement, Summit will merge with Argos North America Corp. (“Argos”). The companies will combine in a cash and stock transaction valued at $3.2 billion. Post close, Argos will have a 31% interest in Summit. The investigation concerns whether the Summit Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of Summit shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/summit-materials-nyse-sum/ .

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

More News

View More
Golden Cross Alert: 3 Stocks With Serious Upside Potential
July 31, 2025
Via MarketBeat
Tickers CSX DDOG GOOGL
Big Beat, Bigger Plans: AEP Stock Powers Up on Data Center Boom
July 31, 2025
Via MarketBeat
Tickers AEP
UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale
July 31, 2025
Via MarketBeat
Topics Economy
Tickers T UPS VZ WBA
Why Byrna Could Be the Top Defense Stock to Watch Now
July 31, 2025
Via MarketBeat
Topics ETFs
Tickers AMZN BYRN SHLD
Why Bloom Energy Stock Could Break to New Highs
July 31, 2025
Via MarketBeat
Tickers BE
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap